1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Osteopenia - Pipeline Review, H2 2014

Osteopenia - Pipeline Review, H2 2014

  • December 2014
  • -
  • Global Markets Direct
  • -
  • 36 pages

Osteopenia - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Osteopenia - Pipeline Review, H2 2014’, provides an overview of the Osteopenia’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Osteopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteopenia and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Osteopenia
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Osteopenia and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Osteopenia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Osteopenia pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Osteopenia
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Osteopenia pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Contents

Osteopenia - Pipeline Review, H2 2014
Table of Contents
Introduction 5
Global Markets Direct Report Coverage 5
Osteopenia Overview 6
Therapeutics Development 7
Pipeline Products for Osteopenia - Overview 7
Pipeline Products for Osteopenia - Comparative Analysis 8
Osteopenia - Therapeutics under Development by Companies 9
Osteopenia - Therapeutics under Investigation by Universities/Institutes 10
Osteopenia - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Osteopenia - Products under Development by Companies 13
Osteopenia - Products under Investigation by Universities/Institutes 14
Osteopenia - Companies Involved in Therapeutics Development 15
AstraZeneca PLC 15
Daiichi Sankyo Company, Limited 16
Zealand Pharma A/S 17
Osteopenia - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 24
Drug Profiles 26
AZD-4017 - Drug Profile 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Small Molecules for Osteopenia and Bone Disorders - Drug Profile 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
Small Molecules for Osteopenia and Osteoporosis - Drug Profile 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
Sodium Quinate - Drug Profile 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
ZP-2307 - Drug Profile 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
Osteopenia - Recent Pipeline Updates 32
Osteopenia - Dormant Projects 33
Osteopenia - Discontinued Products 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables

Number of Products under Development for Osteopenia, H2 2014 7
Number of Products under Development for Osteopenia - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Number of Products under Investigation by Universities/Institutes, H2 2014 10
Comparative Analysis by Clinical Stage Development, H2 2014 11
Comparative Analysis by Early Stage Development, H2 2014 12
Products under Development by Companies, H2 2014 13
Products under Investigation by Universities/Institutes, H2 2014 14
Osteopenia - Pipeline by AstraZeneca PLC, H2 2014 15
Osteopenia - Pipeline by Daiichi Sankyo Company, Limited, H2 2014 16
Osteopenia - Pipeline by Zealand Pharma A/S, H2 2014 17
Assessment by Monotherapy Products, H2 2014 18
Number of Products by Stage and Target, H2 2014 20
Number of Products by Stage and Mechanism of Action, H2 2014 22
Number of Products by Stage and Route of Administration, H2 2014 23
Number of Products by Stage and Molecule Type, H2 2014 25
Osteopenia Therapeutics - Recent Pipeline Updates, H2 2014 32
Osteopenia - Dormant Projects, H2 2014 33
Osteopenia - Discontinued Products, H2 2014 34

List of Figures

Number of Products under Development for Osteopenia, H2 2014 7
Number of Products under Development for Osteopenia - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Early Stage Products, H2 2014 12
Assessment by Monotherapy Products, H2 2014 18
Number of Products by Top 10 Targets, H2 2014 19
Number of Products by Stage and Top 10 Targets, H2 2014 19
Number of Products by Top 10 Mechanism of Actions, H2 2014 21
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 21
Number of Products by Top 10 Molecule Types, H2 2014 24
Number of Products by Stage and Top 10 Molecule Types, H2 2014 24

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

  • $ 1995
  • Industry report
  • November 2016
  • by Plunkett Research

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2023, NAIC ...

Specialized Design Services Global Market Analytics 2016

Specialized Design Services Global Market Analytics 2016

  • $ 1500
  • Industry report
  • November 2016
  • by TBRC Business Research

Specialized design services comprise companies that are involved in planning, designing and administering projects as per client needs and specifications. The specialized design services market does not ...

Scientific Research And Development Services Global Market Analytics 2016

Scientific Research And Development Services Global Market Analytics 2016

  • $ 1500
  • Industry report
  • November 2016
  • by TBRC Business Research

The scientific research and development services industry comprises establishments engaged in research and experimental development on a contract, consultancy or outsourced basis in the areas such as biotechnology, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.